Cerecin Announces TEDx Talk by CEO Dr. Charles Stacey is Now Available Online
Titled "The Potential of Fasting and Diet in the Future of Medicine" Highlighting the Potential of Ketones - from Fasting, the Ketogenic diet and Pharmaceuticals - to Address Neurological Disease and Improve Brain Health DENVER, Colo., March 5, 2026 /PRNewswire/ -- Cerecin Inc., a clinical-stage biotechnology company developing metabolic drugs for...
China Cycle 2026: Building a Global Platform to Advance Global Cooperation and Innovation
SHANGHAI, March 5, 2026 /PRNewswire/ -- China International Bicycle Fair 2026 (China Cycle 2026) is expected to open May 5–8, 2026 at the Shanghai New International Expo Centre (SNIEC). Leveraging China's strategic position as a global hub for the bicycle industry, this year's trade show will set up an efficient business matching platform for domestic and international enterprises, fostering collaboration...
HM Hospitals and Huawei Jointly Launch a Global Smart Healthcare Showcase
BARCELONA, Spain, March 5, 2026 /PRNewswire/ -- During MWC Barcelona 2026, Huawei held a summit themed "AI+, Accelerating Healthcare Intelligence." The event gathered leading global healthcare experts, academics, and industry partners to envision the new future of digital and intelligent healthcare. At the summit, Huawei teamed up with HM Hospitals, Spain to officially launch the Global Smart Healthcare...
VISTA Eye Carnival 2026 Brings “Malaysia Truly Eye-sia” to Life Across 13 Branches Nationwide
PETALING JAYA, Malaysia, March 5, 2026 /PRNewswire/ -- For many people, clear vision means more than simply seeing well — it means recognising loved ones, driving safely, continuing to work confidently, and fully enjoying everyday experiences. Yet, many Malaysians only seek eye care after vision problems begin affecting their quality of life. Bringing Eye Care...
Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results
HONG KONG, March 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II study (COMPASSION-03/AK104-201) of cadonilimab as a monotherapy for patients with recurrent or metastatic cervical cancer (R/M CC) who have failed prior platinum-containing chemotherapy, were presented in a late-breaking oral...
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint
A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) today announced the launch of its new C> Ecosystem Blueprint — a practical, collaborative approach designed to help cell and gene therapy (C>) developers in the Asia-Pacific (APAC) region move from early development to...
Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference
TAIPEI, March 4, 2026 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced its participation in the 2026 International Patient and Scientific Conference hosted by the Kennedy's Disease Association (KDA). Held between February 27 and March 2, the conference served as a premier forum bringing together patients with Spinal and Bulbar Muscular Atrophy (SBMA), caregivers, clinicians and...
Fedcap Expands Global Footprint with Acquisition of The Community Collective QLD, Entering the Australian Market
NEW YORK and SIPPY DOWNS, Australia, March 5, 2026 /PRNewswire/ -- Fedcap, 90-year old global non-profit advancing economic mobility and wellbeing, today announced the acquisition of The Community Collective QLD (TCCQ), a Queensland-based provider of disability support and employment services in the Sunshine Coast region. This marks Fedcap's strategic expansion into the...
Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026
13 oral presentations included, reaffirming the clinical value of AI-based medical image analysis Highlighting key topics such as early risk stratification based on AI abnormality scores and interval cancer classification SEOUL, South Korea, March 4, 2026 /PRNewswire/ -- Lunit (KRX:32813), a leading provider of AI for cancer diagnostics and precision...
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer Novel combination therapy will be studied as part of the Phase II adaptive platform trial known as the INdividualized Screening trial of Innovative Glioblastoma Therapy (INSIGhT), sponsored by...
